PLIANT THERAPEUTICS, INC. Accounts Payable and Other Accrued Liabilities, Current
PLIANT THERAPEUTICS, INC. (PLRX) had Accounts Payable and Other Accrued Liabilities, Current of $478.00 thousand as of 2026-06-30, per its 10-Q filed 2026-08-11.
Financial Statements › Notes
us-gaap:AccountsPayableAndOtherAccruedLiabilitiesCurrent · last filed 2026-08-11
- 2026-06-30: Accounts Payable and Other Accrued Liabilities, Current $478.00K.
- 2026-03-31: Accounts Payable and Other Accrued Liabilities, Current $1.85M.
- 2025-12-31: Accounts Payable and Other Accrued Liabilities, Current $1.34M.
- 2025-09-30: Accounts Payable and Other Accrued Liabilities, Current $1.22M.
| Period end | Accounts Payable and Other Accrued Liabilities, Current |
|---|---|
| 2026-06-30 | $478.00K 10-Q · filed 2026-08-11 |
| 2026-03-31 | $1.85M 10-Q · filed 2026-05-11 |
| 2025-12-31 | $1.34M 10-Q · filed 2026-08-11 |
| 2025-09-30 | $1.22M 10-Q · filed 2025-11-06 |
| 2025-06-30 | $959.00K 10-Q · filed 2025-08-07 |
| 2025-03-31 | $2.04M 10-Q · filed 2025-05-08 |
| 2024-12-31 | $1.20M 10-K · filed 2026-03-11 |
| 2024-09-30 | $1.29M 10-Q · filed 2024-11-07 |
| 2024-06-30 | $1.59M 10-Q · filed 2024-08-07 |
| 2024-03-31 | $1.33M 10-Q · filed 2024-05-06 |
| 2023-12-31 | $1.18M 10-K · filed 2025-03-03 |
| 2023-09-30 | $1.63M 10-Q · filed 2023-11-09 |
| 2023-06-30 | $1.01M 10-Q · filed 2023-08-09 |
| 2023-03-31 | $1.29M 10-Q · filed 2023-05-09 |
| 2022-12-31 | $1.46M 10-K · filed 2024-02-27 |
| 2022-09-30 | $905.00K 10-Q · filed 2022-11-08 |
| 2022-06-30 | $781.00K 10-Q · filed 2022-08-08 |
| 2022-03-31 | $1.15M 10-Q · filed 2022-05-09 |
| 2021-12-31 | $907.00K 10-K · filed 2023-03-09 |
| 2021-09-30 | $408.00K 10-Q · filed 2021-11-09 |
| 2021-06-30 | $951.00K 10-Q · filed 2021-08-09 |
| 2021-03-31 | $965.00K 10-Q · filed 2021-05-10 |
| 2020-12-31 | $1.68M 10-K · filed 2022-03-01 |
| 2020-09-30 | $1.01M 10-Q · filed 2020-11-10 |
| 2020-06-30 | $2.15M 10-Q · filed 2020-08-11 |
| 2019-12-31 | $1.26M 10-K · filed 2021-03-16 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| TENAX THERAPEUTICS, INC. (TENX) | United States | $0.071B | -7.17 |
| PMV Pharmaceuticals, Inc. (PMVP) | United States | $0.071B | -0.95 |
| Yarrow Bioscience, Inc. (YARW) | United States | $0.070B | |
| Lunai Bioworks Inc. (LNAI) | United States | $0.072B | -0.11 |
| Spero Therapeutics, Inc. (SPRO) | United States | $0.073B | 17.41 |
| Connect Biopharma Holdings Ltd (CNTB) | $0.069B | -2.17 | |
| Cingulate Inc. (CING) | United States | $0.073B | -2.64 |
| Aldeyra Therapeutics, Inc. (ALDX) | United States | $0.074B | -5.57 |
| XBiotech Inc. (XBIT) | United States | $0.066B | -1.56 |
| OS Therapies Inc (OSTX) | United States | $0.076B | -2.17 |